FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/12/098851 [Registered on: 10/12/2025] Trial Registered Prospectively
Last Modified On: 30/10/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   use of arka tail and manshiladi lepa in eczema 
Scientific Title of Study   A Randomized Comparative Trial on the efficacy of Arka Tail and Manashiladi Lepa in the management of vicharchika (SN43) (eczema). 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Rameshwar lal 
Designation  PhD Scholar 
Affiliation  PGIA JODHPUR 
Address  PG Dept of Maulik Siddhant PGIA JODHPUR DSRRAU KARWAR JODHPUR

Jodhpur
RAJASTHAN
342037
India 
Phone  9460054984  
Fax    
Email  drdudi86@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Devendra singh chahar 
Designation  Professor 
Affiliation  PGIA JODHPUR 
Address  PG Dept of Maulik Siddhant PGIA JODHPUR DSRRAU KARWAR JODHPUR

Jodhpur
RAJASTHAN
342037
India 
Phone  9636981669  
Fax    
Email  vddschahar1973@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Rameshwar lal 
Designation  PhD Scholar 
Affiliation  PGIA JODHPUR 
Address  PG Dept of Maulik Siddhant PGIA JODHPUR DSRRAU KARWAR JODHPUR

Jodhpur
RAJASTHAN
342037
India 
Phone  9460054984  
Fax    
Email  drdudi86@gmail.com  
 
Source of Monetary or Material Support  
DSRRAU JODHPUR KARWAR NAGOUR ROAD JODHPUR 342037  
 
Primary Sponsor  
Name  DSRRAU JODHPUR  
Address  DSRRAU JODHPUR KARWAR NAGOUR ROAD JODHPUR 342037  
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rameshwar lal  Sanjeevani hospital  OPD No.10, Sanjeevani hospital, Dr Sarvapalli Radhakrishnana Rajasthan Ayurved University Jodhpur
Jodhpur
RAJASTHAN 
9460054984

drdudi86@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
DRSRAU JODHPUR PGIA   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L209||Atopic dermatitis, unspecified. Ayurveda Condition: VICARCIKA,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Arka taila, Reference: YogratanakarKustha Nidan Chikitsa Prakaran203, Route: Topical, Dosage Form: Taila, Dose: 10(ml), Frequency: bd, Bhaishajya Kal: Muhurmuhu, Duration: 90 Days, anupAna/sahapAna: No, Additional Information: Arka taila will be applied on affected area
2Comparator ArmDrugClassical(1) Medicine Name: Manahshiladi Lepa, Reference: Charaka Su.3/12, Route: Topical, Dosage Form: Lepa Churna, Dose: 10(g), Frequency: bd, Bhaishajya Kal: Muhurmuhu, Duration: 90 Days, anupAna/sahapAna: No, Additional Information: Manashiladi lepa will be applied on the affected area
 
Inclusion Criteria  
Age From  18.00 Day(s)
Age To  60.00 Day(s)
Gender  Both 
Details  Diagnosed Patient of vicharchika according to subjective perameter of samhitas has complaints of itching, Burning sensation,discharge, dryness, eruption, and depigmentation 
 
ExclusionCriteria 
Details  1. Patients suffering from disorders like diabetes Mellitus, systemic infections.
2. Age- below 12 years and above 60 years.
3. patients who are suffering from major psychiatric disorders.
4. Patients suffering from major systemic illnesses like myocardial infraction, Ischemic heart disease, AIDS, Cancer, Major respiratory disease, liver failure, Renal failure and Renal toxicity etc.
 
 
Method of Generating Random Sequence   Permuted block randomization, variable 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Any changes in EASI score  90 days 
 
Secondary Outcome  
Outcome  TimePoints 
Arka Tail and Manashiladi Lepa will provide a safe and effective treatment and improve the quality of life  90 days 
 
Target Sample Size   Total Sample Size="140"
Sample Size from India="140" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   10/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Open to Recruitment 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   It is a randomized, prospective, open- label, interventional comparative clinical trial. the trial consist of two groups: one group will recieve Arka taila as external application. Other group will recieve Manahshiladi lepa as external application.  At the end of the study both groups will be compared for results. 
Close